Latest debt-to-equity ratio
CytoMed Therapeutics Debt-to-equity ratio
Direct answer
CytoMed Therapeutics's debt-to-equity ratio is 8.41%.
The verified market snapshot reports 8.41%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 22, 2026.
Get free CytoMed Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 8.41%
Explore related company data
View CytoMed Therapeutics's market capitalizationView CytoMed Therapeutics's price-to-book ratioView CytoMed Therapeutics's return on equityView CytoMed Therapeutics's dividend yieldView CytoMed Therapeutics's 52-week price rangeView CytoMed Therapeutics's revenue growthView CytoMed Therapeutics's profit marginView all CytoMed Therapeutics key metricsReturn to CytoMed Therapeutics profile